NorthWest Biotherapeutics Inc (NWBO)

[XMaster2023]

Manibiotech, I understand what you’re trying to say. You believe it is better to have everything under one company. However, copilot doesn’t agree with your philosophy. See below and note the penultimate paragraph. It’s called strategy.

it's accurate that Northwest Biotherapeutics (NWBO) utilizes separate manufacturing partners, such as Advent BioServices. Here's a breakdown of what that means and how it relates to smaller biotech companies:
* Outsourcing Manufacturing:
* It's quite common, especially for smaller biotech companies, to outsource manufacturing. This is because building and maintaining specialized manufacturing facilities requires significant capital investment and expertise.
* Companies like NWBO, focusing on research and development, may find it more efficient to partner with contract manufacturing organizations (CMOs) like Advent BioServices.
* Reasons for Outsourcing:
* Cost-effectiveness: Avoiding the high costs of building and maintaining in-house manufacturing.
* Specialized expertise: CMOs often have specialized expertise in specific types of manufacturing, such as cell therapies, which can be complex.
* Flexibility: Outsourcing allows companies to scale production up or down as needed.
* Regulatory compliance: CMOs are often well-versed in the complex regulatory requirements for pharmaceutical manufacturing.
* NWBO's Situation:
* NWBO has utilized different manufacturing partners for its DCVax® products, including Cognate and Advent BioServices, for different geographic locations. This shows that the company has used outsourcing as a part of its production strategy.
* The information available indicates the company has worked to establish and obtain the required lisences for commercial manufacturing with Advent BioServices.
In summary, it is typical for smaller biomed companies to outsource manufacturing.